SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹199 Cr | ₹42 Cr | ₹617 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹199 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹617 Cr |
How is Cash Flow from Financing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹199 Cr | 369.89 | |
| Mar2024 | ₹42 Cr | -93.12 | |
| Mar2023 | ₹617 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,536.5 Cr | -4.8% | 22% | -5.3% | Stock Analytics | |
| SAGILITY INDIA | ₹19,483.7 Cr | -1.1% | 4.2% | 1.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹19,275.2 Cr | 9% | 22.4% | -24.2% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,060.8 Cr | -1.2% | 16.6% | -27.9% | Stock Analytics | |
| JUST DIAL | ₹4,476.3 Cr | -1.8% | 7.7% | -44% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,494.3 Cr | -0.3% | 51.1% | -45.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.8% |
22% |
-5.3% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses